Board of Directors

Daniel G. Welch

Biotechnology Executive
(Executive Chairman)

Myles D. Greenberg, MD, MBA

President & Chief Executive Officer, InCarda Therapeutics

Isaac Cheng, M.D.

Morningside Venture

Johan Christenson, M.D., Ph.D.

HealthCap

Alan Colowick, M.D., M.P.H.

Matrix Capital Management

Andrew ElBardissi, M.D.

Deerfield Management

Louis G. Lange, M.D., Ph.D.

BOD Observer

For more information about InCarda: